The "Properties of the Apathy Scale (AS) for use on Parkinson’s patients" is not designed for self-administration but heteropalicación. It could be considered the agreement between the two forms of application, but in subjects given a grade level.
to evaluate the apathy in patients affected by Parkinson's Disease, you could employ the self-rated version of Apathy Evaluation Scale (which did not consider the possible effect of the severity of motor symptoms) or self-rated version of the Dimensional Apathy Scale which is validated in PD patients. It is possible to use a cut-off score to screen apathetic PD patients both using Apathy Evaluation Scale and Dimensional Apathy Scale. The cut-off score have been found according to clinical diagnostic criteria for apathy. The references of the validation studies are the following:
Santangelo G, D'Iorio A, Piscopo F, Cuoco S, Longo K, Amboni M, Baiano C,
Tafuri D, Pellecchia MT, Barone P, Vitale C. Assessment of apathy minimising the
effect of motor dysfunctions in Parkinson's disease: a validation study of the
dimensional apathy scale. Qual Life Res. 2017 Apr 7. doi:
10.1007/s11136-017-1569-6. [Epub ahead of print] PubMed PMID: 28389975.
Santangelo G, Barone P, Cuoco S, Raimo S, Pezzella D, Picillo M, Erro R,
Moccia M, Pellecchia MT, Amboni M, Santangelo F, Grossi D, Trojano L, Vitale C.
Apathy in untreated, de novo patients with Parkinson's disease: validation study
of Apathy Evaluation Scale. J Neurol. 2014 Dec;261(12):2319-28. doi: